Moderate to Severe Chronic Plaque Psoriasis
3 competing products in clinical development for Moderate to Severe Chronic Plaque Psoriasis.
Pipeline by Phase
Phase 2/31
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Alefacept | Astellas Pharma | Approved | Completed | 43 |
| Tildrakizumab + Placebo + Tildrakizumab + Tildrakizumab + Tildrakizumab + Etanercept + Placebo | Sun Pharmaceutical | Phase 2/3 | Active | 42 |
| CT-P17 + EU-approved Humira | Celltrion | Phase 3 | Completed | 40 |